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Abstract The goal of this study was to compare the sur-
vival rate and functional outcome of an open partial hori-
zontal laryngectomies, Type IIa and modified Type IIa
(OPHL Type IIa and OPHL mType IIa), in treatment of
moderately advanced glottic carcinoma. Retrospective ana-
lysis. 80 Patients underwent OPHL Type IIa and 27, OPHL
modified Type IIa (OPHL mType IIa) between the years
2001 and 2009. Clinical staging was performed according to
the UICC criteria (2002). Primary endpoints of study were
recurrence rate, and 3- and 5-year survival time. Secondary
endpoints were laryngeal functions: respiration, swallowing
and voice. There were no significant differences within local
and regional recurrence rates, organ preservation rate, 3- and
5-year specific disease survival rates between OPHL Type II
and OPHL modified Type IIa. Significantly lower need for
temporary (OPHL mType IIa 4/27, OPHL Type IIa 30/80)
and permanent tracheostomy (OPHL mType IIa 2/27, OPHL
Type IIa 16/80) was found. All but one patient (OPHL Type
IIa) achieved unrestricted diet. Significantly differed social
eating, this ability gained 25/27 OPHL mType IIa and 54/80
OPHL Type IIa (p\ 0.05). Voice handicap index revealed a
decrease in quality of life in all areas; OPHL Type IIa and
OPHL mType IIa differed significantly (31 and 46 points
respectively, p\ 0.005). The MPT value (longest pitch) for
OPHL Type IIa and OPHL mType IIa lasted 8 s and 10,
respectively (p\ 0.005). There was no significant difference
in oncological outcomes between the two types of OPHL
succeeded in the earlier extubation, thus significantly low-
ering the need for temporary and permanent tracheotomy and
providing better long-term swallowing. Although the voice
was altered in all observed OPHL patients, modified Type IIa
technique proved to be superior to the Type IIa in terms of
voice quality. Thus, OPHL modified Type IIa is worth pro-
moting, as long as indications were strictly conformed.
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Introduction
Balance between morbidities: voice function, risk of per-
sistent aspiration, higher risk for elderly and good onco-
logical outcomes of supracricoid partial laryngectomies
(SCPL) have been widely discussed in literature [1–3]. The
modification of Laccourry technique of the SCPL with
crico-hyoido-epiglottopexy (CHEP) was presented by Wen
et al. [4], and Maoxiao and Renyu [5]. They preserved
fragments of both thyroid laminas to better support the
cartilage framework, to avoid stenosis and to protect
swallowing function. The presented reconstruction was
based on a cricothyroidopexy (CTP) in which the upper
parts of thyroid laminas (not exceeding 0.5 cm) were fixed
with the vicryl sutures to the cricoid cartilage, and the
ventricular folds were preserved except of the region of
anterior commissure (AC). This reconstructive technique
resembled transglottic resection described by Calearo [6],
but it differed in the amount of cartilage preservation;
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originally it encompassed the upper third of the laminas.
The excellent oncological results of Calearo technique
were presented [7], but indications for this surgery were
limited to T1b glottic cancer with AC involvement.
According to a recent proposal of the European Lar-
yngological Society (ELS) working committee on nomen-
clature or a systematic classification of open partial
laryngectomies (OPHL), supracricoid laryngectomy with
cricohyoido-epiglottopexy—CHEP, constitute Type IIa of
OPHL [8]. Thus we presented the comparison of OPHL
Type IIa and its modification, OPHL modified Type IIa.
The spread of a tumor from the glottis might occur
either by AC invasion or by extension through the ventri-
cles. Therefore, in tumors larger than T1b, the upper
resection border should exceed the level of ventricular
folds to obtain the safe margins. Since 2005, we have
introduced the modified OPHL Type IIa (mType IIa) for
the middle stage of glottic carcinoma and observed that
functional effects of preserving even the small thyroid
cartilage remnants have been beneficial for the functional
outcomes. This technique is based on the laryngeal inlet
resection that is as wide as that performed in Type IIa
procedure and includes the mucosa and inner perichon-
drium to the limits of ventricular folds and the epiglottic
petiole if needed, however, there is simultaneous mainte-
nance of thyroid cartilage strips, upper laryngeal nerve,
vessels and at least one crico-arytenoid unit. We assumed
that conditions created during OPHL mType IIa to obtain
improved neoglottis function were not contrary to onco-
logical principles and safety. The aim of this paper is to
investigate and compare the treatment outcomes of OPHL
Type IIa and OPHL modified Type IIa in moderately
advanced glottis cancer T2b and specific T3 cases.
Materials and methods
To address the research purpose, the investigators designed
and implemented the retrospective analysis of 107 patients
with glottic cancer T2b with AC involvement. All patients
were surgically treated with curative intent at the University
Department of Otolaryngology, tertiary referral center and
presented for evaluation and management between 01.2005
and 12.2009. The study was approved by the Poznan´ Uni-
versity Ethics Committee. The treatment protocol for the
neck and the primary was based on Head and Neck NCCN
version 1.2005, published in Polish literature in 2010 [9].
Tumor staging
To be included in the study sample, patient has to have
TNM stage evaluation according to the 2009 AJCC clas-
sification [10] detailed description of tumor localization in
medical charts, operative reports and histological structure
assessments according to the WHO classification (2005).
Computed tomography to assess the primary and an
ultrasound of the neck combined with FNAC (fine needle
aspiration cytology) were performed if regional involve-
ment was suspected. All patients underwent the microlar-
yngoscopy for biopsy and direct larynx assessment under
general anesthesia. Patients were excluded as study sub-
jects when the data were insufficient (n = 1), second
primaries (n = 3) or distant metastases at the time of
diagnosis were present (n = 1), or histology revealed the
presence of a cancer other than squamous cell carcinoma
(adenoid cystic carcinoma and neuroendocrine n = 2).
Finally, all 107 patients who met the inclusion criteria had
to be eligible to re-evaluation. The age of patients ranged
from 30 to 73 years, mean 56.5, median 57; 12 (11.2 %)
women and 95 (88.8 %) men were treated.
Treatment
The study population was composed of the 2 cohorts of 80
and 27 consecutive patients treated by means of OPHL
Type IIa or OPHL modified Type IIa (OPHL mType IIa).
Medical conditions that could define patients as being
selected for OPHL Type II include the extensive infiltration
of the ventricle fold level (T3 ac AJCC). OPHL mType IIa
was reserved for glottis cancer with extension not
exceeding the ventricle (T2b). In the examined sample
seven patients had their arytenoid resected. The group
characteristics are shown in Table 1. Out of 19 patients
undergoing elective neck dissection at the time of laryngeal
primary treatment, 3 were pN1. Surgery was followed by
adjuvant radiotherapy (RT) in 7 patients; 5 (8.8 %) OPHL
Type IIa and 2 OPHL mType IIa (3.7 %).
Follow-up
The patients were routinely followed up every 6 weeks in
the first 2 years and every 3 months in the 3rd–5th year.
Table 1 Patients characteristic
Primary treatment modality OPHL Type IIa OPHL mType IIa
No. of patients 80 27
Age mean/median 55.2/55.0 60.2/61
Women/men 10/70 2/25
Adverse findings
Positive margins 2 2
Positive nodes (N?) 3 0
Adjuvant RT 5 2
OPHL Type IIa open partial horizontal laryngectomy Type IIa, OPHL
mTape IIa open partial horizontal laryngectomy modified Type IIa
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The minimal duration of a follow-up for the examined
sample was 36 months.
The laryngoscopy and stroboscopy to assess the glottis
was the mainstay of examination; the impact was put to
exclude the local recurrence. Formation of webs, granulo-
mas or hypertrophic mucosa was documented and patients
were directed to microsurgery if they had complaints or if
the larynx picture was not stable; laser procedures were
performed if postoperative stenosis caused subjective
dyspnoe. If local recurrence occurred, the method of sal-
vage was analyzed with special regard to feasibility of
larynx preservation.
Swallowing was assessed in 1 month and 1 year after
the treatment, the Pearson-Leipzig scale [11, 12] was used.
Every patient was asked two questions with the closed
structure (yes or no): if they tolerate an unrestricted diet
and if they can eat in social setting.
The voice handicap index (VHI) survey and maximum
phonation time examination (MPT) were performed during
the follow-up visit 1 year after the surgery. The VHI
questionnaire assessed the impact of voice deterioration on
their quality of life in functional, physical and emotional
domains; using 10 questions scored 0–4 each, summed up
to 120 points as maximum. The MPT value was obtained
after three attempts of deep breathing with ‘‘a’’ phonation,
the longest pitch was noted.
End points and statistical analysis
The main predictor variable was the treatment modality
OPHL Type IIa and OPHL mType IIa. Age and gender
were additional predictor variables. Patients characteristics
were compared by Fisher’s exact test, Chi-square test and
Kruskal–Wallis test. The primary outcome variables were:
local recurrence rate, 3 years local control rate, the possible
salvage treatment, 3 years organ preservation rate, 3 and
5 years disease specific survival and 3 and 5 years overall
survival. They were calculated using Kaplan–Meier with
the log-rank test assessing equality of distributions. Sec-
ondary outcome variables were function-related and
included breathing, swallowing and quality of voice. The
patients were observed for early complications such as
postoperative bleeding, subcutaneous emphysema, lar-
yngeal fistula, difficulty in extubation or nasogastric tube
removal and pneumonia. The late major complications in
this series included dyspnea and aspiration. Student’s test
was used for comparing proportions; all analyses were
performed by SPSS for windows, version 15.0.
Results
Local control
There were 107 patients available for the 4 year assessment
and 70 for the 5 year assessment. The disease control and
survival outcomes with regard to treatment modality are
listed in Table 2. Nine (8.4 %) patients failed primary
treatment, local relapse was observed in 9 patients between
12 and 36 month of follow-up (median 16 months). Local
recurrence occurred in 7 (8.75 %) OPHL Type IIa and 2
(7.40 %) OPHL mType IIa, the difference was not statis-
tically significant (p[ 0.05). The recurrence was found in
6/95 (6.31 %) men and in 3/12 (25 %) women, the dif-
ference was statistically significant (p\ 0.05). 3 years
local control rates for OPHL Type IIa and OPHL mType
IIa were 92.50 and 85.71 %, respectively. 5-year local
control rates for OPHL Type IIa and OPHL mType IIa
reached 82.46 and 66.67 %, respectively. No recurrences
were observed in seven patients who were administered
adjuvant radiotherapy for the adverse findings (positive
margins, positive nodes) during primary surgery.
Larynx preservation
No patients were salvaged by transoral laser or partial
surgery. Total laryngectomy was indispensible in all 9
Table 2 Oncological outcomes
and local failure
OPHL Type IIa open partial
horizontal laryngectomy Type
IIa, OPHL mType IIa open
partial horizontal laryngectomy
modified Type IIa
a Data available for 70/107
patients
Primary treatment modality Total OPHL Type IIa OPHL mType IIa p
No. of patients 107 80 27
Local recurrence rate 9 7 (8.75) 2 (7.4) [0.05
Regional recurrence rate 15 (14 %) 12 (15 %) 3 (11 %) \0.005
3 years local control rate 63/107 92.50 % 85.71 % 0.24012
5 years local control ratea 47/107 82.46 % 66.67 % 0.12491
3 years organ preservation rate 63/107 92.50 % 85.71 % 0.24012
5 years organ preservation ratea 47/107 80 % 50 % 0.16802
3 years disease specific survival ratea 54/107 92.59 % 94.12 % 0.3364
5 years disease specific survival ratea 44/107 89.19 % 85.71 % 0.4841
3 years overall survival ratea 87/107 91.04 % 95.00 % 0.2074
5 years overall survival ratea 57/107 83.33 % 77.78 % 0.4137
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recurrences: 7 (8.75 %) OPHL Type IIa and 2 (7.40 %)
OPHL mType IIa; there was no statistical difference
between primary surgery modalities (p = 0.987) for the
organ preservation rate. Salvage total laryngectomy was
performed in 6/95 men and in 3/12 women, difference was
statistically significant (p = 0.028). 3 and 5 years local
control rates were equal with 3 and 5 organ preservation
rates.
Regional control
Nodal relapse was observed in 15 patients between 12 and
36 months of follow-up (median 25.6 months); neck dis-
section was required and metastases were confirmed in all
patients. The rates for treatment modalities were: 15 % for
OPHL Type IIa and 11 % for OPHL mType IIa, this dif-
ference was not significant (p\ 0.005).
Survival
Three patients died in preoperative period from cardiac
stroke. Two patients died of regional disease in 12th and
22nd month, respectively. For the whole group 3-year
disease specific survival was 92.59 % (OPHL Type IIa),
94.12 % (OPHL mType IIa), 5-year overall survival was
83.33 % (OPHL Type IIa) 77.78 % (OPHL mType IIa).
Differences between the two treatment modalities were,
therefore, not statistically significant.
Postoperative complications
Early postoperative complications in the OPHL cohort
included subcutaneous emphysema (12 patients), bleeding
(5 patients), aspiration and pneumonia (1 patient). Wound
revision was done in the first (1 patient), second (3 patients),
and fifth (1 patient) day after surgery. The patient with
aspiration pneumonia required antibiotics, physiotherapy
and nasogastric tube maintaining for 2 weeks. There were no
differences between two treatment modalities.
Functional outcomes
Major complications in this series included dyspnea and
aspiration. Specific types and incidence of functional fail-
ures according to treatment modality are presented in
Table 3. A significantly lower need for temporary trache-
otomy was found with OPHL mType IIa (4/27) than Type
IIa (30/80) (p = 0.0512). Attempts to widen the airway
lumen were undertaken in all these patients. Montgomery T
tube was inserted in one patient after OPHL Type IIa. A
laser procedure was used to widen the glottis in 28 patients:
4 OPHL mType IIa and 24 OPHL Type IIa, the difference
between both treatment modalities was statistically
significant (p = 0.1939). Sixteen patients were success-
fully decannulated in 3 months. A significantly lower need
for permanent tracheostomy was found with OPHL mType
IIa (2/27) than OPHL Type IIa (16/80) (p = 0.2244).
Swallowing abilities were assessed for six categories. The
first measurement in the immediate postoperative period was
the mean time until the nasogastric tube removal; in OPHL
mType IIa and OPHL Type IIa, there were 11 and 13 days,
respectively. Permanent gastrostomy was required in only
one OPHL Type IIa case. Every patient was asked two
questions (demanded answer was ‘yes’ or ‘no’): if they tol-
erate an unrestricted diet and if they can eat in social setting.
All patients except one with gastrostomy declared that they
had unrestricted diet. More troublesome was their ability to
partake in social eating, which was reeducated in 25/27
Table 3 Functional outcomes according to treatment modalities




No. of patients 107 80 27
Early postoperative outcome measures
Mean day of extubation 7.598 7.750 7.148




Bleeding 5 5 0
Pneumonia 1 1 0
Subcutaneous oedema 12 8 4
Breathing























Unrestricted diet 107 79 27
Social eating 79 54 25
Voice




OPHL Type IIa open partial horizontal laryngectomy Type IIa, OPHL
mType IIa open partial horizontal laryngectomy modified Type IIa
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OPHL mType IIa and in 54/80 OPHL Type IIa cases. The
OPHL mType IIa provided better chances for undisturbed
public dining (p = 0.0208).
The voice was analyzed in two categories. The VHI
questionnaire assessing the impact of voice deterioration
revealed the meaningful decrease in the life quality in
functional, physical and emotional domains; with 31/120
points for OPHL Type IIa group and 46/120 points for
OPHL mType IIa group. The MPT value (longest pitch),
obtained after three attempts of deep breathing with ‘‘a’’
phonation, for both treatment modalities: OPHL Type IIA
and OPHL mType IIa lasted 8 and 10.11 s, respectively,
the difference was not significant (p\ 0.005).
Discussion
The long-term oncological and functional outcomes of T2b
and selected T3 glottic cancer treated by OPHL Type IIa
and its modified version OPHL mType IIa, in which the
upper borders of both thyroid cartilage laminas were pre-
served, were investigated, compared to each other and
discussed in relation to other.
Oncological outcomes
In our series, the whole OPHL group achieved overall
survival, disease specific survival, local control rate and
organ preservation rate 89.71 %. Superior oncological
outcomes, mainly measured by local control rates ranged in
literature from 79.1 to 93.94 % and were confirmed by
numerous authors [13–20] with highest score 97 % given
by Laudadio et al. [21].
Treatment modalities available for T2 glottic cancer
include a wide range of open surgical techniques, with
vertical partial laryngectomy (VPL) or frontal anterior
laryngectomy (FA) among them. Zhang et al. [22] found a
significantly lower post-operative local recurrence rate in
SCPL-CHEP than in VPL groups (2.6 vs. 17.8 %,
p = 0.033). In contrast, favorable oncological results for
vertical procedures presented Hartl et al. [23] with local
control rate of 83 % for tumors with cartilage invasion and
94 % for those without invasion; difference was not sig-
nificant, which was probably due to systematic resection of
thyroid cartilage. Bakhos et al. [14] compared FA laryn-
gectomy and CHEP, which is used more often when there
was contra-lateral vocal fold spread; 5-year survival rate
was 95 and 85 %, respectively, local tumor control was
obtained in 87 in 83 %, respectively, but CHEP resulted in
better postoperative outcomes. Wen et al. [4] presented the
SCPL modalities: CTP and CHEP with recurrence rates 13
and 15 %, respectively.
Predictors of local control and survival were presented
by Gallo et al. [16] in 253 samples. Univariate and multi-
variate analyses showed that a positive resection margin
was the only important predictor of local control. A report
on 291 patients by Page et al. [17] estimated the local
(laryngeal) control rate to be 93.94 % and regional (cer-
vical lymph node) control rate to be 92.05 %; in multi-
variate analysis, the occurrence of a second non-ENT
cancer, distant metastases and margins involvement were
reliable to mortality. The significantly higher frequency of
local recurrence among women in OPHL, in our opinion,
was related to smaller dimensions of the female larynx,
compromising the efforts of the surgeon to obtain free
margins.
Functional outcomes
Early outcomes: in our study higher rates of the swallowing
problems were connected with OPHL Type IIa than with
mType IIa. The time to nasogastric tube removal was an
important outcome measure in the early post-operative
period. In the literature this varied notably from 3 to
134 days [24]. In our sample the median time of naso-
gastric tube removal was 12 days (11 days for OPHL
mType IIa). The swallowing rehabilitation was conducted
during the hospital stay, and patients were discharged when
thick liquids could be consumed.
Late outcomes are dyspnea, aspiration and swallowing
problems [25–27]. In our Department the planned trache-
otomy was not included in our operating schedule. Tem-
porary tracheotomy was needed in 34 patients but 14/30 in
OPHL Type IIa and 2/4 in OPHL mType IIa were dec-
annulated in time. Lucioni et al. [28] noticed that 8 % of
225 patients had laryngeal stenosis; all underwent CO2
laser one or two times, decannulation was possible in all
patients except in one; authors concluded that the only
reasonable contra-indication to CO2 laser could be a cra-
nio-caudal length of the laryngeal stenotic tract longer than
1 cm. In the own 28 cases (24 OPHL Type IIa, 4 OPHL
mType IIa), the CO2 laser was used to widen the neo-
glottis. In two females tracheotomy was needed in 2 and
6 months postoperatively but no attempts to widen the
airway lumen were undertaken. Finally, 16/80 (20 %)
OPHL Type IIa and 2/27 (7.4 %) OPHL mType IIa
patients required permanent tracheotomy.
The compensation mechanism for swallowing after
SCPL is antero-medial rotation of the remaining arytenoids
that make contact with epiglottis in concordance with
flexion of epiglottis, following posterior tongue movement
[29, 30]. Crico-arytenoid unit preservation (cricoid carti-
lage and at least one mobile arytenoid cartilage) constitutes
the most important condition of the effective swallowing
rehabilitation. Including the arytenoids into resection
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margin, as in extended SCPL with both arytenoids exci-
sion, presented by Rifai et al. [31] was feasible, but active
swallowing rehabilitation was principally needed. Alican-
dri-Ciuffiei et al. [32] sampled 106 patients and found the
non-typical conformations and anomalous positioning of
the epiglottis, and involvement of the lateral pharyngeal
wall in the sphincteric and vibratory function of the neo-
glottis. On the other hand, complete epiglottis prolapse,
which obstructed the neoglottis was described in three
cases by Nakayama et al. [33]. In our study seven patients
had one arytenoid resected; and it was combined with the
transverse formation of the neoglottis and mucosal fold
prolapse in five cases.
Deglutition is the main cause of morbidity in open partial
laryngectomies, but the results reported in literature have been
very diverse. In Farrag et al. [34], all 24 patients had a tra-
cheostomy and percutaneous endoscopic gastrostomy (PEG)
tube placement performed at the time of SCPL, with a median
time to decannulation and PEG tube removal of 37 and
70 days, respectively. In 18 patients, Clayburgh et al. [35]
showed similarly bad results, with an average decannulation
time of 27.4 days, feeding tube removal at 87.9 days post-
operatively and 67 % of patients tolerated an unrestricted diet
at follow-up. Oysu et al. [36] compared the near total laryn-
gectomy and CHEP technique; mean decannulation time was
27 and 20 days, respectively, and average nasogastric tubes
removal at 23 and 17 days, respectively. In contrast to the
presented above unsatisfactory results, Simonelli et al. [37]
based on large sample (n = 116), concluded that patients with
functional deglutition after SCPL showed a mild and well-
tolerated degree of chronic aspiration and did not require
limited oral intake. Nakayama et al. [20] observed that swal-
lowing function (ability to eat in public) was acquired in 28/30
(93 %) irradiated and 39/43 (91 %) non-irradiated patients.
Bussi et al. [38] removed the nasogastric tube in CHEP and
CHP groups after an average 16 days, and good deglutition
was recorded in 41 of the 44 cases (93.18 %) and adequate
deglutition in the remaining 3 cases. In our series, unrestricted
diet at 1 month was achieved by all of patients except one, in
whom gastrostomy was needed; social eating declared 54/80
(67.5 %) CHEP and 25/27 (92.6 %) mCTP patients. The
mCTP technique was shown to be valuable because it did not
disturb oral intake.
Voice
Primary RT seems to be the voice preserving treatment
modality [39] but less effective oncologically. On the other
hand, all manipulations in AC region worsen the glottis
closure. Wen et al. [4] reported that SCPL-CTP group had
significantly lower VHI scores, higher maximum phonation
time and improved glottis closure than the SCPL-CHEP
group. In the samples of Oysu et al. [36], the mean VHI
score was 55.58 in the CHEP group and 52.78 in the near
total laryngectomy group. The detailed voice outcomes of
250 SCPL patients operated on in our Department have
been presented elsewhere [40]. In the present study, the
quality of voice after treatment was analyzed by means of
the physical subscale of the VHI and MPT examination.
The VHI results differ between the examined cohorts:
31/120 in CHEP and 46/120 in mCTP were found, and
MPT achieved 8 and 10.1 s, respectively. The mCTP
technique was superior to CHEP in terms of voice quality.
Conclusion
To summarize, there was no significant differences in the
oncological outcomes between two surgical OPHL tech-
niques (Type IIa and modified Type IIa). The OPHL Type
IIa modification, mType IIa, was superior in earlier extu-
bation, with significantly lower need for temporary and
permanent tracheotomy, and better swallowing. Although
the voice was altered in all analyzed OPHL patients, the
modified Type IIa technique appeared to be superior to
Type IIa in terms of voice quality. Thus, OPHL modified
Type IIa is worth promoting, as long as indications for
surgery were strictly confirmed.
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